Human medicinal agents from plants
Author(s)
Bibliographic Information
Human medicinal agents from plants
(ACS symposium series, 534)
American Chemical Society, 1993
Available at 14 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
"Developed from a symposium sponsored by the Division of Agricultural and Food Chemistry at the 203rd National Meeting of the American Chemical Society, San Francisco, California, April 5-10, 1992."
Includes bibliographical references and indexes
Description and Table of Contents
Description
Covers the discovery, development, use and potential use, and regulation of plant-derived drugs. Describes ongoing research for prospective natural drugs with anticancer and anti-infective activities. Features some highly promising compounds, including artemisinin, camptothecin, forskolin, and taxol. Includes coverage of biologically active constituents of terrestrial and marine plants. Also addresses the effects of the destruction of rain forests on drug
discovery.
Table of Contents
- Plant-Derived Natural Products in Drug Discovery and Development: An Overview
- Tropical Forest Biodiversity and the Potential for New Medicinal Plants
- Phytomedicines in Western Europe: Potential Impact on Herbal Medicine in the United States
- Biological and Chemical Diversity and the Search for New Pharmaceuticals and Other Bioactive Natural Products
- The Renaissance of Plant Research in the Pharmaceutical Industry
- Secondary Metabolism in Plant Tissue Cultures Transformed with Agrobacterium tumefaciens and Agrobacterium rhizogenes
- Role of Plants in the National Cancer Institute Drug Discovery and Development Program
- Logistics and Politics in Plant Drug Discovery: The Other End of the Spectrum
- Simple Bench-Top Bioassays (Brine Shrimp and Potato Discs) for the Discovery of Plant Antitumor Compounds: Review of Recent Progress
- Taxol, an Exciting Anticancer Drug from Taxus brevifolia: An Overview
- Camptothecin and Analogues: Synthesis, Biological In Vitro and In Vivo Activities, and Clinical Possibilities
- Antineoplastic Agents and Their Analogues from Chinese Traditional Medicine
- Novel Strategies for the Discovery of Plant-Derived Anticancer Agents
- Cancer Chemopreventive Agents: From Plant Materials to Clinical Intervention Trials
- National Cancer Institute Intramural Research on HIV-Inhibitory and Antitumor Plant Natural Products
- Discovery and Development of Novel Prototype Antibiotics for Opportunistic Infections Related to Acquired Immunodeficiency Syndrome
- Artemisia annua: From Weed to Respectable Antimalarial Plant
- Search for Molluscicidal and Larvicidal Agents from Plants
- Algal Secondary Metabolites and Their Pharmaceutical Potential
- Activation of the Isotypes of Protein Kinase C and Other Kinases by Phorbol Esters of Different Biological Activities
- Bioactive Organosulfur Compounds of Garlic and Garlic Products: Role in Reducing Blood Lipids
- Rohitukine and Forskolin: Second-Generation Immunomodulatory, Intraocular-Pressure-Lowering, and Cardiotonic Analogues
by "Nielsen BookData"